Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS)
CNY 19.98
(1.16%)
CNY 19.98
(1.16%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.08 CNY | 17.39% |
| 2022 | 0.92 CNY | 53.33% |
| 2021 | 0.60 CNY | -40.59% |
| 2020 | 1.01 CNY | -31.76% |
| 2019 | 1.48 CNY | 15.63% |
| 2018 | 1.28 CNY | 80.28% |
| 2017 | 0.71 CNY | -20.22% |
| 2016 | 0.89 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.07 CNY | -64.33% |
| 2024 Q1 | 0.21 CNY | -34.38% |
| 2024 Q3 | 0.11 CNY | 46.86% |
| 2023 Q4 | 0.32 CNY | 14.29% |
| 2023 FY | - CNY | 17.39% |
| 2023 Q3 | 0.28 CNY | 0.0% |
| 2023 Q2 | 0.28 CNY | 40.0% |
| 2023 Q1 | 0.20 CNY | -47.37% |
| 2022 FY | - CNY | 53.33% |
| 2022 Q3 | 0.17 CNY | 0.0% |
| 2022 Q2 | 0.17 CNY | -15.0% |
| 2022 Q1 | 0.20 CNY | 53.85% |
| 2022 Q4 | 0.38 CNY | 123.53% |
| 2021 Q2 | 0.30 CNY | 36.36% |
| 2021 Q1 | 0.22 CNY | 260.66% |
| 2021 FY | - CNY | -40.59% |
| 2021 Q4 | 0.13 CNY | 406.6% |
| 2021 Q3 | -0.04 CNY | -114.13% |
| 2020 FY | - CNY | -31.76% |
| 2020 Q4 | 0.06 CNY | -67.89% |
| 2020 Q3 | 0.19 CNY | -73.24% |
| 2020 Q2 | 0.71 CNY | 787.5% |
| 2020 Q1 | 0.08 CNY | -80.95% |
| 2019 Q4 | 0.42 CNY | -16.0% |
| 2019 Q3 | 0.50 CNY | 0.0% |
| 2019 FY | - CNY | 15.63% |
| 2018 FY | - CNY | 80.28% |
| 2017 FY | - CNY | -20.22% |
| 2016 FY | - CNY | 0.0% |